These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 30405416)

  • 41. Quantifying the tendency of therapeutic target proteins to bind promiscuous or selective compounds.
    Hu Y; Bajorath J
    PLoS One; 2015; 10(5):e0126838. PubMed ID: 26000736
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Novel Computational Approach to Predict Off-Target Interactions for Small Molecules.
    Rao MS; Gupta R; Liguori MJ; Hu M; Huang X; Mantena SR; Mittelstadt SW; Blomme EAG; Van Vleet TR
    Front Big Data; 2019; 2():25. PubMed ID: 33693348
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Detecting similar binding pockets to enable systems polypharmacology.
    Duran-Frigola M; Siragusa L; Ruppin E; Barril X; Cruciani G; Aloy P
    PLoS Comput Biol; 2017 Jun; 13(6):e1005522. PubMed ID: 28662117
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Virtual Reverse Screening Approach to Target Type 2 Cannabinoid Receptor.
    Ciriaco F; Gambacorta N; Leonetti F; Altomare CD; Nicolotti O
    Methods Mol Biol; 2023; 2576():495-504. PubMed ID: 36152212
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Resveratrol in the treatment of asthma based on an animal model.
    Leis K; Gałązka P; Kazik J; Jamrożek T; Bereźnicka W; Czajkowski R
    Postepy Dermatol Alergol; 2022 Jun; 39(3):433-438. PubMed ID: 35950118
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The resveratrol analogue 4,4'-dihydroxy-trans-stilbene inhibits cell proliferation with higher efficiency but different mechanism from resveratrol.
    Savio M; Coppa T; Bianchi L; Vannini V; Maga G; Forti L; Cazzalini O; Lazzè MC; Perucca P; Prosperi E; Stivala LA
    Int J Biochem Cell Biol; 2009 Dec; 41(12):2493-502. PubMed ID: 19679195
    [TBL] [Abstract][Full Text] [Related]  

  • 47. New enlightenment of French Paradox: resveratrol's potential for cancer chemoprevention and anti-cancer therapy.
    Liu BL; Zhang X; Zhang W; Zhen HN
    Cancer Biol Ther; 2007 Dec; 6(12):1833-6. PubMed ID: 18087218
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Molecular Mingling: Multimodal Predictions of Ligand Promiscuity in Pentameric Ligand-Gated Ion Channels.
    Koniuszewski F; Vogel FD; Bampali K; Fabjan J; Seidel T; Scholze P; Schmiedhofer PB; Langer T; Ernst M
    Front Mol Biosci; 2022; 9():860246. PubMed ID: 35615739
    [No Abstract]   [Full Text] [Related]  

  • 49. Resveratrol: a multitargeted agent for age-associated chronic diseases.
    Harikumar KB; Aggarwal BB
    Cell Cycle; 2008 Apr; 7(8):1020-35. PubMed ID: 18414053
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Rational application of drug promiscuity in medicinal chemistry.
    Mei Y; Yang B
    Future Med Chem; 2018 Aug; 10(15):1835-1851. PubMed ID: 30019924
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Web-Based Tools for Polypharmacology Prediction.
    Awale M; Reymond JL
    Methods Mol Biol; 2019; 1888():255-272. PubMed ID: 30519952
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Quantitative Polypharmacology Profiling Based on a Multifingerprint Similarity Predictive Approach.
    Ciriaco F; Gambacorta N; Alberga D; Nicolotti O
    J Chem Inf Model; 2021 Oct; 61(10):4868-4876. PubMed ID: 34570498
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Resveratrol in peanuts.
    Sales JM; Resurreccion AV
    Crit Rev Food Sci Nutr; 2014; 54(6):734-70. PubMed ID: 24345046
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Creation of a free, Internet-accessible database: the Multiple Target Ligand Database.
    Chen C; He Y; Wu J; Zhou J
    J Cheminform; 2015; 7():14. PubMed ID: 25897329
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Polypharmacology prediction: the long road toward comprehensively anticipating small-molecule selectivity to de-risk drug discovery.
    Manen-Freixa L; Antolin AA
    Expert Opin Drug Discov; 2024 Jul; ():1-27. PubMed ID: 39004919
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Multi-target Polypharmacology of 4-aminoquinoline Compounds against Malaria, Tuberculosis and Cancer.
    Nandi S; Chauhan B; Tarannum H; Khede MK
    Curr Top Med Chem; 2023; 23(5):403-414. PubMed ID: 36694313
    [TBL] [Abstract][Full Text] [Related]  

  • 57. GES polypharmacology fingerprints: a novel approach for drug repositioning.
    Pérez-Nueno VI; Karaboga AS; Souchet M; Ritchie DW
    J Chem Inf Model; 2014 Mar; 54(3):720-34. PubMed ID: 24494653
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Target-specific compound selectivity for multi-target drug discovery and repurposing.
    Wang T; Pulkkinen OI; Aittokallio T
    Front Pharmacol; 2022; 13():1003480. PubMed ID: 36225560
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Resveratrol and cardiovascular system-the unfulfilled hopes.
    Chudzińska M; Rogowicz D; Wołowiec Ł; Banach J; Sielski S; Bujak R; Sinkiewicz A; Grześk G
    Ir J Med Sci; 2021 Aug; 190(3):981-986. PubMed ID: 33219913
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Quantitative and systems pharmacology 2. In silico polypharmacology of G protein-coupled receptor ligands via network-based approaches.
    Wu Z; Lu W; Yu W; Wang T; Li W; Liu G; Zhang H; Pang X; Huang J; Liu M; Cheng F; Tang Y
    Pharmacol Res; 2018 Mar; 129():400-413. PubMed ID: 29133212
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.